EED and follicular lymphoma: Recently, analogs of EED226 (e.g., EEDi-5285) have been further developed and optimized with an enhanced binding affinity for EED and the ability to inhibit growth in mouse xenograft models of human follicular lymphoma (He et al., 2017; Rej et al., 2021).